USPTO serial 79425354
PP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 12, 2026
- Examiner
- FOX III, LYAL L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals, biological preparations, and biochemical preparations for use in industry and science; Chemicals for use in biotechnological manufacturing processes | ACTIVE | — |
| 005 | Chemical and biochemical preparations for pharmaceutical or medical purposes for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction, and pain; Biological reagents for medical purposes; Biologics in the nature of pharmaceutical preparations for the treatment of for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction, and pain; Biochemical reagents for medical purposes; Diagnostic preparations for medical purposes; Reagents for medical purposes; Vaccines; Pharmaceutical preparations for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction, and pain; Sedatives; Anaesthetics; Hypnotics; Anxiolytics; Muscle relaxants; Anticonvulsants; Analgesics; Antibiotic preparations; Antiparasitics; Antihypertensives; Antihypotensives; Pharmaceutical preparations, namely, immunostimulants; Pharmaceutical preparations for gene therapy for the treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction, and pain | ACTIVE | — |
| 035 | Wholesale store services, retail store services, mail order services, online wholesale store services, and online retail store services featuring chemical, biological, and biochemical preparations for industrial, scientific, medical, veterinary and pharmaceutical purposes, and also featuring diagnostic preparations for medical purposes, reagents for medical purposes, vaccines, pharmaceutical preparations, and pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Paion Pharma GmbH
- Other trademarks owned by Paion Pharma GmbH
- Other trademarks owned by Paion Pharma GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 035
- Similar marks named PP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 12, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 12, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 12, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 24, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 24, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 18, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 27, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 27, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 27, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 27, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 27, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 21, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 21, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 21, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 21, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 21, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 7, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 17, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 17, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 3, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 2, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 29, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 3, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 6, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 6, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 5, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |